Therapeutic Advances in Endocrinology and Metabolism · Published 2025-12-01 · DOI 10.1177/20420188251406531
Background: Metabolic disorders significantly contribute to global morbidity and mortality. However, data on these trends in the Arab region remain limited despite rising obesity rates and declining metabolic health. Objectives: This study aims to investigate the trends and burdens of metabolic diseases, including diabetes mellitus, cardiovascular disease (CVD), chronic kidney disease (CKD), metabolic dysfunction-associated fatty liver disease (MAFLD), and ischemic stroke and related risk factors in the Arab region. Design: A retrospective analysis of metabolic diseases based on the Global Burden of Disease 2021 database. Methods: We analyzed age-standardized rates of disease prevalence, incidence, mortality, and disability-adjusted life years (DALYs) from 1990 to 2021, using data from the Global Burden of Disease Study 2021. Results: In 2021, the Arab region faced a substantial burden: 34.6 million with diabetes, 30.8 million with CVD, 32 million with CKD, 109.4 million with MAFLD, and 3 million with stroke. Mortality and DALYs for these diseases often exceeded global averages. Conclusion: The Arab region faces a significant public health challenge due to increasing metabolic disease burdens and inconsistent mortality reduction. A comprehensive approach addressing lifestyle factors and improving healthcare access is crucial to improving health outcomes and managing this growing burden.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →